Article: Cancer Vaccines Scientists See Hope for Cervical Cancer Vaccine

Scientists who hope one day to immunize girls against cervical cancer have begun the first human testing of a possible vaccine.

It's far too soon to know if Merck & Co.'s experimental vaccine, described at a biotechnology meeting, will work. The company is in the first stage of testing, to make sure the vaccine is safe enough to study in large numbers of women. But it's a long-awaited step.

"We have an exciting opportunity," said Dr. Katherin Jansen, Merck, as she reported that the vaccine seemed highly effective in animals.

At issue is human papilloma virus (HPV), the nation's most common sexually transmitted disease.

Up to 40 million Americans ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!